We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current PNVL3 market cap is 1.31B. The company's latest EPS is BRL 0.6178 and P/E is 14.10.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | |
| Total Revenue | 1.17B | 1.22B | 1.32B | 1.32B | 1.22B |
| Operating Income | 40.21M | 42.6M | 46.2M | 50.29M | 23.01M |
| Net Income | 22.03M | 23.65M | 29.01M | 33.55M | 5.13M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | |
| Total Revenue | 2.87B | 2.99B | 3.47B | 4.28B | 4.8B |
| Operating Income | 119.77M | 94.01M | 101.53M | 137.29M | 166.57M |
| Net Income | 76.76M | 56.15M | 79.43M | 86.35M | 92.91M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | |
| Total Assets | 2.78B | 2.95B | 3.08B | 3.2B | 3.15B |
| Total Liabilities | 1.66B | 1.81B | 1.9B | 2.01B | 1.98B |
| Total Equity | 1.13B | 1.14B | 1.17B | 1.2B | 1.17B |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | |
| Total Assets | 1.46B | 2.19B | 2.38B | 2.73B | 3.08B |
| Total Liabilities | 936.11M | 1.18B | 1.33B | 1.62B | 1.9B |
| Total Equity | 524.18M | 1.01B | 1.05B | 1.11B | 1.17B |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | |
| Operating | 92.09M | 169.72M | 296.62M | 16.07M | 116.76M |
| Investing | -99.68M | -193.43M | -196.56M | -41.03M | -75.84M |
| Financing | -5.85M | 13.57M | -97.83M | 19.14M | -52.18M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | |
| Operating | 128.8M | 130.98M | 131.86M | 205.48M | 296.62M |
| Investing | -53.87M | -390.5M | 14.91M | -131.09M | -196.56M |
| Financing | -42.63M | 318.19M | -222.44M | -103.12M | -97.83M |
| Market Cap | 1.31B |
| Price to Earnings Ratio | 14.10 |
| Price to Sales Ratio | 0.27 |
| Price to Cash Ratio | 46.85 |
| Price to Book Ratio | 1.12 |
| Dividend Yield | 0.71% |
| Shares Outstanding | 150.38M |
| Average Volume (1 week) | 346.06k |
| Average Volume (1 Month) | 442.73k |
| 52 Week Change | -30.87% |
| 52 Week High | 13.36 |
| 52 Week Low | 8.64 |
| Spread (Intraday) | 0.5 (5.56%) |
| Company Name | Dimed Sa (ex Panvel Sa Drogarias Farmacias) |
| Address |
avenida industrial belgraff, 865 predio 100 porto alegre, rio grande do sul 92990-000 |
| Website | https://www.panvel.com.br |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
